Asia-Pacific Uterine Cancer Therapeutics Market by Type [Uterine Sarcoma and Endometrial Carcinoma (Adenocarcinoma, Carcinosarcoma, Squamous cell carcinoma, & Others)] and by Therapy (Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, & Hormone Therapy)- Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Asia-Pacific Uterine Cancer Therapeutics Market by Type [Uterine Sarcoma and Endometrial Carcinoma (Adenocarcinoma, Carcinosarcoma, Squamous cell carcinoma, & Others)] and by Therapy (Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, & Hormone Therapy)- Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 1492 | Pages: 135 | November 2016 | Region: Asia Pacific


Asia-Pacific Uterine Cancer Therapeutics Market is expected to reach $3,724.5 million by 2021 from $2,696.9 million in 2016, growing at a CAGR of 6.67% during the forecast period 2016-2021. Uterine cancer is one of most commonly prevailing malignant tumours that starts in the cells of the uterus and spreads to other parts of the body. Uterine cancer is mainly of two types such as uterine sarcoma and endometrial carcinoma. Till now more numbers of therapies have been evolved to manage uterine cancer types include surgery, chemotherapy, radiation therapy, immunotherapy, and hormone therapy.

Increasing focus of government to provide early detection programs for uterine cancer, rising provision of optimal therapeutic strategies to treat uterine cancer, growing economy, and increasing advancements in the cancer screening & treatment methods are driving the growth of Asia-Pacific Uterine Cancer Therapeutics Market. However, high cost of the treatment solutions, limited access for advanced cancer therapies in certain developing areas are expected to restrain the growth of Uterine Cancer Therapeutics Market.

Asia-Pacific Market for Uterine Cancer Therapeutics is broadly categorized into type and therapy. On the basis of type Asia-Pacific Uterine Cancer Therapeutics market is segmented into Uterine Sarcoma and Endometrial Carcinoma (Adenocarcinoma, Carcinosarcoma, Squamous cell carcinoma, & Others). Of these, Endometrial Carcinoma is expected to hold the major market share in Asia-Pacific Uterine Cancer Therapeutics market. Based on therapy the market is segmented into Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, and Hormone Therapy.

Geographically, Asia-Pacific Uterine Cancer therapeutics market is segmented into China, India, Japan, South Korea, and Australia. Asia-Pacific is the fastest growing region with a CAGR of 6.67% during the forecast period 2016-2021.

Key market players in Uterine Cancer Therapeutics market such as Abbott Laboratories (U.S.), Ariad Pharmaceuticals, Inc. (U.S.), Becton, Dickinson and Company (U.S.), F. Hoffmann-La Roche AG (Switzerland), GlaxoSmithKline Plc (U.K.), Merck & Co., Inc. (U.S.), Novartis AG (Switzerland), Sanofi (France), Siemens Healthcare GmbH (Germany), and Takeda Pharmaceutical Company Ltd. (Japan).

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Type                        

                                5.1.1 Endometrial Carcinoma     

                                                5.1.2.1 Adenocarcinoma

                                                5.1.2.2 Carcinosarcoma

                                                5.1.2.3 Squamous cell carcinoma

                                                5.1.2.4 Others

                                5.1.2 Uterine Sarcoma  

                5.2 By Therapy                 

                                5.2.1 Surgery    

                                5.2.2 Chemotherapy     

                                5.2.3 Radiation Therapy

                                5.2.4 Immunotherapy   

                                5.2.5 Hormone Therapy

6. Geographical Analysis                                              

                6.1 Introduction                              

                6.2 China                            

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea               

                6.6 Australia                      

7. Pipeline Product Analysis                                        

                7.1 Overview                    

                7.2 Pipeline Development Landscape                     

                7.3 Molecular Targets in the Pipeline                      

                7.4 Clinical Trials                              

                                7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target       

                                7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target                

                                7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target               

8.Strategic Analysis                                        

                8.1 PESTLE analysis                         

                                8.1.1 Political     

                                8.1.2 Economic 

                                8.1.3 Social         

                                8.1.4 Technological         

                                8.1.5 Legal          

                                8.1.6 Environmental      

                8.2 Porter’s Five analysis                              

                                8.2.1 Bargaining Power of Suppliers        

                                8.2.2 Bargaining Power of Consumers    

                                8.2.3 Threat of New Entrants     

                                8.2.4 Threat of Substitute Products and Services

                                8.2.5 Competitive Rivalry within the Industry      

9.Market Leaders' Analysis                                          

                9.1 Abbott Laboratories (U.S.)                   

                                9.1.1 Overview

                                9.1.2 Product Analysis   

                                9.1.3 Financial analysis  

                                9.1.4 Recent Developments       

                                9.1.5 SWOT analysis       

                                9.1.6 Analyst View          

                9.2 Ariad Pharmaceuticals, Inc. (U.S.)                     

                9.3 Becton, Dickinson and Company (U.S.)                           

                9.4 F. Hoffmann-La Roche AG (Switzerland)                        

                9.5 GlaxoSmithKline Plc (U.K.)                   

                9.6 Merck & Co., Inc. (U.S.)                         

                9.7 Novartis AG (Switzerland)                    

                9.8 Sanofi (France)                         

                9.9 Siemens Healthcare GmbH (Germany)                           

                9.10 Takeda Pharmaceutical Company Ltd. (Japan)                          

10.Competitive Landscape                                          

                10.1 Market share analysis                          

                10.2 Merger and Acquisition Analysis                     

                10.3 Agreements, collaborations and Joint Ventures                       

                10.4 New Product Launches                       

11.Market Outlook & Investment Opportunities                               

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia-Pacific Uterine Cancer Therapeutics Market By Region, From 2016-2021 ( USD Million )
  2. Asia-Pacific Uterine Cancer Therapeutics Market By Type, From 2016-2021 ( USD Million )
  3. Asia-Pacific Endometrial Carcinoma Market By Region, From 2016-2021 ( USD Million )
  4. Asia-Pacific Uterine Sarcoma Market By Region, From 2016-2021 ( USD Million )
  5. Asia-Pacific Uterine Cancer Therapeutics Market By Therapy, From 2016-2021 ( USD Million )
  6. Asia-Pacific Uterine Cancer Surgery Market By Region, From 2016-2021 ( USD Million )
  7. Asia-Pacific Uterine Cancer Chemotherapy Market By Region, From 2016-2021 ( USD Million )
  8. Asia-Pacific Uterine Cancer Immunotherapy Market By Region, From 2016-2021 ( USD Million )
  9. Asia-Pacific Uterine Cancer Radiation Therapy Market By Region, From 2016-2021 ( USD Million )
  10. Asia-Pacific Uterine Cancer Hormone Therapy Market By Region, From 2016-2021 ( USD Million )
  11. China Uterine Cancer Therapeutics Market By Type, From 2016-2021 ( USD Million )
  12. China Uterine Cancer Therapeutics Market By Therapy, From 2016-2021 ( USD Million )
  13. India Uterine Cancer Therapeutics Market By Type, From 2016-2021 ( USD Million )
  14. India Uterine Cancer Therapeutics Market By Therapy, From 2016-2021 ( USD Million )
  15. Japan Uterine Cancer Therapeutics Market By Type, From 2016-2021 ( USD Million )
  16. Japan Uterine Cancer Therapeutics Market By Therapy, From 2016-2021 ( USD Million )
  17. South Korea Uterine Cancer Therapeutics Market By Type, From 2016-2021 ( USD Million )
  18. South Korea Uterine Cancer Therapeutics Market By Therapy, From 2016-2021 ( USD Million )
  19. Australia Uterine Cancer Therapeutics Market By Type, From 2016-2021 ( USD Million )
  20. Australia Uterine Cancer Therapeutics Market By Therapy, From 2016-2021 ( USD Million )
  21. Asia-Pacific Endometrial Carcinoma Market By Type, From 2016-2021 ( USD Million )
  22. Asia-Pacific Adenocarcinoma Market By Region, From 2016-2021 ( USD Million )
  23. Asia-Pacific Carcinosarcoma Market By Region, From 2016-2021 ( USD Million )
  24. Asia-Pacific Squamous cell carcinoma Market By Region, From 2016-2021 ( USD Million )
  25. Asia-Pacific Other Endometrial Carcinoma Market By Region, From 2016-2021 ( USD Million )
  26. China Endometrial Carcinoma Market By Type, From 2016-2021 ( USD Million )
  27. India Endometrial Carcinoma Market By Type, From 2016-2021 ( USD Million )
  28. Japan Endometrial Carcinoma Market By Type, From 2016-2021 ( USD Million )
  29. South Korea Endometrial Carcinoma Market By Type, From 2016-2021 ( USD Million )
  30. Australia Endometrial Carcinoma Market By Type, From 2016-2021 ( USD Million )
Middle East And Africa Psychiatry Therapies Market By Type (Social Psychology, Abnormal Psychology, Biological Psychology And Other Types), By Type Of Medication (Antidepressants, Antipsychotics, Depressants, Anxiol...
Latin America Psychiatry Therapies Market By Type (Social Psychology, Abnormal Psychology, Biological Psychology And Other Types), By Type Of Medication (Antidepressants, Antipsychotics, Depressants, Anxiolytics, Mo...
Asia Pacific Psychiatry Therapies Market By Type (Social Psychology, Abnormal Psychology, Biological Psychology And Other Types), By Type Of Medication (Antidepressants, Antipsychotics, Depressants, Anxiolytics, Moo...
Europe Psychiatry Therapies Market By Type (Social Psychology, Abnormal Psychology, Biological Psychology And Other Types), By Type Of Medication (Antidepressants, Antipsychotics, Depressants, Anxiolytics, Mood Stab...
North America Psychiatry Therapies Market By Type (Social Psychology, Abnormal Psychology, Biological Psychology And Other Types), By Type Of Medication (Antidepressants, Antipsychotics, Depressants, Anxiolytics, Mo...
Psychiatry Therapies Market By Type (Social Psychology, Abnormal Psychology, Biological Psychology And Other Types), By Type Of Medication (Antidepressants, Antipsychotics, Depressants, Anxiolytics, Mood Stabilisers...
Middle East and Africa Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Servic...
Latin America Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unski...
Asia-Pacific Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unskil...
Europe Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unskilled Ca...
North America Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unski...
Home Healthcare Market by Product (Mobility Care Products ,Screening, & Monitoring Products, Testing, Therapeutic Products) by Service (Infusion Therapy Services, Rehabilitation Therapy Services, Unskilled Care Serv...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.